The Cav2.3 calcium channel antagonist SNX‐482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain
- 28 June 2007
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 25 (12) , 3561-3569
- https://doi.org/10.1111/j.1460-9568.2007.05605.x
Abstract
Neuropathic pain is a difficult state to treat, characterized by alterations in sensory processing that can include allodynia (touch‐evoked pain). Evidence exists for nerve damage‐induced plasticity in both transmission and modulatory systems, including changes in voltage‐dependent calcium channel (VDCC) expression and function; however, the role of Cav2.3 calcium channels has not clearly been defined. Here, the effects of SNX‐482, a selective Cav2.3 antagonist, on sensory transmission at the spinal cord level have been investigated in the rat. The spinal nerve ligation (SNL) model of chronic neuropathic pain [Kim & Chung, (1992)Pain, 50, 355–363] was used to induce mechanical allodynia, as tested on the ipsilateral hindpaw. In vivo electrophysiological measurements of dorsal horn neuronal responses to innocuous and noxious electrical and natural stimuli were made after SNL and compared to sham‐operated animals. Spinal SNX‐482 (0.5–4 µg/50 µL) exerted dose‐related inhibitions of noxious C‐fibre‐ and Aδ‐fibre‐mediated neuronal responses in conditions of neuropathy, but not in sham‐operated animals. Measures of spinal cord hyperexcitability and nociception were most susceptible to SNX‐482. In contrast, non‐noxious Aβ‐mediated responses were not affected by SNX‐482. Moreover, responses to innocuous mechanical and also thermal stimuli were more sensitive to SNX‐482 in SNL than control animals. This study is the first to demonstrate an antinociceptive role for SNX‐482‐sensitive channels in dorsal horn neurons during neuropathy. These data are consistent with plasticity in CaV2.3 calcium channel expression and suggest a potential selective target to reduce nociceptive transmission during conditions of nerve damage.Keywords
This publication has 46 references indexed in Scilit:
- Identification of the α2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalinProceedings of the National Academy of Sciences, 2006
- The Cav2.3 voltage-gated calcium channel in epileptogenesis—Shedding new light on an enigmatic channelNeuroscience & Biobehavioral Reviews, 2006
- Altered Seizure Susceptibility in Mice Lacking the Cav2.3 E‐type Ca2+ ChannelEpilepsia, 2006
- Presynaptic ‘Cav2.3‐containing’ E‐type Ca2+ channels share dual roles during neurotransmitter releaseEuropean Journal of Neuroscience, 2005
- Blocking the R‐type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine toleranceEuropean Journal of Neuroscience, 2004
- Functional Specialization of Presynaptic Cav2.3 Ca2+ ChannelsNeuron, 2003
- The CaV2.3 Ca2+ channel subunit contributes to R‐Type Ca2+ currents in murine hippocampal and neocortical neuronesThe Journal of Physiology, 2002
- Novel ω-Conotoxins from Conus catus Discriminate among Neuronal Calcium Channel SubtypesJournal of Biological Chemistry, 2000
- The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium ChannelJournal of Biological Chemistry, 1996
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983